SCHEMBL3626522

SCHEMBL3626522

C[C@@H](CO)OC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7601768 1.00
SCHEMBL2383537 1.00
SCHEMBL29728566 0.81 TSHR (0.60)
SCHEMBL4009243 0.80
SCHEMBL28384882 0.80
SCHEMBL23725742 0.79
SCHEMBL473155 0.79
SCHEMBL3504870 0.79
SCHEMBL225530 0.79 TSHR (0.58)
SCHEMBL25200468 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110637015-A Farnesoin X receptor agonists and uses thereof 梅塔科林公司 2019-12-31 CN claimed
EP-1266900-A1 Carbamates of rapamycin Wyeth (US) 2002-12-18 EP claimed
EP-0593227-A1 Carbamates of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-20 EP claimed
US-5302584-A Immunosuppressants AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-12 US claimed
CN-117897146-A Novel process for synthesizing enantiomerically pure (S) -methadone, (R) -methadone, racemic (R, S) -methadone and related analogues 保罗·L·曼佛雷蒂 2024-04-16 CN disclosed
CN-117651699-A Compounds and compositions for the treatment of coronavirus related diseases 诺华股份有限公司 2024-03-05 CN disclosed
CN-117377665-A PARP7 inhibitor and application thereof 北京华森英诺生物科技有限公司 2024-01-09 CN disclosed
WO-2023243686-A1 DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF 日本たばこ産業株式会社 2023-12-21 WO disclosed
CN-117120429-A KHK inhibitor 吉利德科学公司 2023-11-24 CN disclosed
CN-116848114-A Tricyclic derivatives useful as PARP7 inhibitors 北京加科思新药研发有限公司 2023-10-03 CN disclosed
CN-116396228-A Uracil PARP7 inhibitors 上海湃隆生物科技有限公司 2023-07-07 CN disclosed
CN-116406272-A DNA-PK selective inhibitor and preparation method and application thereof 首药控股(北京)股份有限公司 2023-07-07 CN disclosed
US-20100273223-A1 New Calb Muteins and Their Use BASF SE (DE) 2010-10-28 US disclosed
WO-2010003624-A2 HETEROCYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THE USE THEREOF SANOFI-AVENTIS (FR) 2010-01-14 WO disclosed
WO-2009080676-A1 NEW CALB MUTEINS AND THEIR USE BASF SE (DE) 2009-07-02 WO disclosed
EP-1266900-A1 Carbamates of rapamycin Wyeth (US) 2002-12-18 EP disclosed
WO-1998011112-A1 TRICYCLIC INDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF SYNTHELABO (FR) 1998-03-19 WO disclosed
US-5411967-A Antiinflammatory, immunosuppressant, antitumor AMERICAN HOME PRODUCTS CORPORATION (US) 1995-05-02 US disclosed
EP-0593227-A1 Carbamates of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-20 EP disclosed
US-5302584-A Immunosuppressants AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-12 US disclosed